{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:43:02Z","timestamp":1790808182365,"version":"4.1.0"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Systemic sclerosis (SSc) is rare, severe connective tissue disease characterized by endothelial and vascular damage, immune activation, and resulting in inflammation and fibrosis of skin and internal organs, including the heart. SSc is associated with high morbidity and mortality. Cardiac involvement is frequent in SSc patients, even though often asymptomatic at early stages, and represents one of the major causes of SSc-related mortality. Heart involvement has a variable clinical presentation, and its pathogenesis is not completely understood. Myocardial fibrosis is traditionally considered the immunopathologic hallmark of heart involvement in SSc. This unique histological feature is paralleled by distinctive clinical and prognostic features. The so-called \u201cvascular hypothesis\u201d represents the most credited hypothesis to explain myocardial fibrosis. More recently, the prominent role of an inflammatory myocardial process has been identified as a cardinal event in the evolution to fibrosis, thus also delineating an \u201cinflammation-driven pathway to fibrosis\u201d. The pro-inflammatory cytokine interleukin (IL)-1 has an apical and cardinal role in the myocardial inflammatory cascade and in cardiac dysfunction. The primary aim of this perspective article is: to present the emerging evidence on the role of IL-1 and inflammasome in both SSc and heart inflammation, to review the complex interplay between cellular metabolism and inflammasome activation, and to discuss the rationale for targeted inhibition of IL-1 for the treatment of SSc-heart involvement, providing preliminary experimental and clinical data to support this hypothesis.<\/jats:p>","DOI":"10.3389\/fimmu.2021.653950","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T06:01:37Z","timestamp":1616479297000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement"],"prefix":"10.3389","volume":"12","author":[{"given":"Giacomo","family":"De Luca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Campochiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tomelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.rdc.2007.12.002","article-title":"The heart in scleroderma","volume":"34","author":"Champion","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the Systemic sclerosis myocarditis EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/2397198317747441","article-title":"Update on assessment and management of primary cardiac involvement in systemic sclerosis","volume":"3","author":"Bournia","year":"2018","journal-title":"J scleroderma Relat Disord"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.07.006","article-title":"Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression","volume":"43","author":"Pieroni","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153012","article-title":"Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome","volume":"11","author":"De Luca","year":"2016","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100480","article-title":"Implantable cardioverter defibrillator prevents sudden death in systemic sclerosis","volume":"38","author":"Bernardo","year":"2011","journal-title":"J Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.012","article-title":"Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis","volume":"76","author":"Peretto","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijcard.2017.03.088","article-title":"QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk","volume":"239","author":"De Luca","year":"2017","journal-title":"Int J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5301\/jsrd.5000244","article-title":"High sensitivity troponin might be a marker of subclinical scleroderma heart involvement: a preliminary study","volume":"2","author":"Barsotti","year":"2017","journal-title":"J scleroderma Relat Disord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez658","article-title":"Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis","volume":"59","author":"De Luca","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/239719831876288","article-title":"Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis","volume":"3","author":"Lee","year":"2018","journal-title":"J scleroderma Relat Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.53.3.483","article-title":"Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03009742.2018.1493744","article-title":"Unexpected acute lymphocytic virus-negative myocarditis in a patient with limited cutaneous systemic sclerosis: a case report","volume":"30","author":"De Luca","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1415921","article-title":"Troponin in stable ischemic heart disease and diabetes","volume":"373","author":"Bosello","year":"2015","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/03009742.2016.1157626","article-title":"Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst","volume":"46","author":"De Luca","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/03009742.2016.1157626","article-title":"Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst","volume":"46","author":"De Luca","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.11.104","article-title":"Impact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditis","volume":"280","author":"Peretto","year":"2019","journal-title":"Int J Cardiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126707","article-title":"Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy","volume":"10","author":"Mueller","year":"2015","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"4","author":"Westermann","year":"2011","journal-title":"Circ Heart Fail"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035144","article-title":"Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF \u03b2\/Smad activation and cardiac fibrosis induced by angiotensin II","volume":"7","author":"Ma","year":"2012","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/srep23010","article-title":"Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGF\u03b21 and miR-29 pathways","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13075-017-1331-z","article-title":"Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis","volume":"19","author":"Artlett","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00881","article-title":"IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways","author":"Mitchell","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01335","article-title":"Myocarditis: An Interleukin-1-Mediated Disease","author":"De Luca","year":"2018","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/ni1110-973","article-title":"IL-1 family nomenclature","volume":"11","author":"Dinarello","year":"2010","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.003698","article-title":"Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue","volume":"293","author":"Ballak","year":"2018","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216233","article-title":"Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout","volume":"79","author":"Kl\u00fcck","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1619011114","article-title":"Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance","volume":"114","author":"Cavalli","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102763","article-title":"Interleukin 1\u03b1: a comprehensive review on the role of IL-1\u03b1 in the pathogenesis and targeted treatment of autoimmune and inflammatory diseases","volume":"20","author":"Cavalli","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.01.015","article-title":"Autophagy and Protein Secretion","volume":"432","author":"Cavalli","year":"2020","journal-title":"J Mol Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-009-0024-y","article-title":"The role of IL-1 in the pathogenesis of heart disease","volume":"57","author":"Bujak","year":"2009","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12605","article-title":"Suppression of inflammation and acquired immunity by IL-37","volume":"281","author":"Cavalli","year":"2018","journal-title":"Immunol Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02025","article-title":"The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis","volume":"10","author":"Xu","year":"2019","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.163.7.3969","article-title":"Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha","volume":"163","author":"Higgins","year":"1999","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4304","article-title":"Endogenous IL-1a fromsystemic sclerosis fibroblasts induces IL-6 and PDGF-A","volume":"103","author":"Kawaguchi","year":"1999","journal-title":"J Clin Invest"},{"key":"B37","article-title":"Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts","volume":"31","author":"Kawaguchi","year":"2004","journal-title":"J Rheumatol"},{"key":"B38","first-page":"5","article-title":"Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients","volume":"17","author":"Mart\u00ednez-God\u00ednez","year":"2015","journal-title":"Isr Med Assoc J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/art.30568","article-title":"The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis","volume":"63","author":"Artlett","year":"2011","journal-title":"Arthritis Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.08.003","article-title":"Targeting TLRs and the inflammasome in systemic sclerosis","volume":"192","author":"Henderson","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1278436","article-title":"MicroRNA as a Therapeutic Target in Cardiac Remodeling","volume":"2017","author":"Chen","year":"2017","journal-title":"BioMed Res Int"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1039\/c6mb00649c","article-title":"miR-155 regulates high glucose-induced cardiac fibrosis via the TGF-\u03b2 signaling pathway","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol Biosyst"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7584","article-title":"Inhibition of microRNA-155 ameliorates cardiac fibrosis in the process of angiotensin II-induced cardiac remodeling","volume":"16","author":"Wei","year":"2017","journal-title":"Mol Med Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.019224","article-title":"Alterations of mononuclear inflammatory cells, CD4\/CD8+ T cells, interleukin 1b, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis","volume":"58","author":"Hussein","year":"2005","journal-title":"J\u00a0Clin Pathol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.05.026","article-title":"IL-1b and TGFb2 synergistically induce endothelial to mesenchymal transition in an NFkappaB-dependent manner","volume":"218","author":"Maleszewska","year":"2013","journal-title":"Immunobiology."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8797-7","article-title":"Association of interleukin-1 family cytokines single nucleotide polymorphisms with susceptibility to systemic sclerosis: an independent case-control study and a meta-analysis","volume":"64","author":"Huang","year":"2016","journal-title":"Immunol Res"},{"key":"B47","article-title":"Interleukin 1a single-nucleotide polymorphism associated with systemic sclerosis","volume":"31","author":"Hutyrova","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/art.10736","article-title":"Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population","volume":"48","author":"Kawaguchi","year":"2003","journal-title":"Arthritis Rheumatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/iji.12212","article-title":"IL-1A rs1800587, IL-1B rs1143634 and IL-1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis","volume":"42","author":"Abtahi","year":"2015","journal-title":"Int J Immunogenet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198693","article-title":"Meta-analyses of IL1A polymorphisms and the risk of several autoimmune diseases published in databases","volume":"13","author":"Su","year":"2018","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imr.12620","article-title":"Interleukin 1 gene polymorphism and susceptibility to disease","volume":"281","author":"Khazim","year":"2018","journal-title":"Immunol Rev"},{"key":"B52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.metabol.2018.12.004","article-title":"The role of metabolism in the pathogenesis of systemic sclerosis","volume":"93","author":"Zhu","year":"2019","journal-title":"Metabolism."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3390\/cells9081808","article-title":"The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging","volume":"9","author":"Meyers","year":"2020","journal-title":"Cells."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214432","article-title":"3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target: Annals of the Rheumatic Diseases","volume":"78","author":"Villa","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.7326\/L20-0092","article-title":"A Novel Histiocytosis With Synovial and Skin Involvement","volume-title":"Ann Internal Med","author":"Cavalli","year":"2020"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1440929","article-title":"The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease","volume":"7","author":"Pacini","year":"2018","journal-title":"OncoImmunology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.70","article-title":"Rathmell J. A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-010-0445-x","article-title":"Clinical value of 18F-fluorodeoxyglucose positron emission tomography in patients with connective tissue disease","volume":"28","author":"Nishiyama","year":"2010","journal-title":"Jpn J Radiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"14026\u2013","DOI":"10.1111\/jcmm.16013","article-title":"Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis","volume":"24","author":"Henderson","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation","volume":"24","author":"Lampropoulou","year":"2016","journal-title":"Cell Metab"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01896","article-title":"The Nrf2-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma","volume":"9","author":"Kavian","year":"2018","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172412","article-title":"KHG21834 attenuates glutamate-induced mitochondrial damage, apoptosis, and NLRP3 inflammasome activation in SH-SY5Y human neuroblastoma cells","volume":"856","author":"Yang","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.05.015","article-title":"Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation","volume":"38","author":"Yan","year":"2013","journal-title":"Immunity"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097957","article-title":"Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-\u03baB activation and enhancing autophagy","volume":"9","author":"Williams-Bey","year":"2014","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archderm.105.1.59","article-title":"Alteration of subcutaneous tissue in systemic scleroderma","volume":"105","author":"Fleischmajer","year":"1972","journal-title":"Arch Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.12.137","article-title":"Formation of the inflammasome in acute myocarditis","volume":"171","author":"Toldo","year":"2014","journal-title":"Int J Cardiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1113\/expphysiol.2012.069021","article-title":"The heart on fire: inflammasome and cardiomyopathy","volume":"98","author":"Abbate","year":"2013","journal-title":"Exp Physiol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003199","article-title":"Targeting interleukin-1 in heart disease","volume":"128","author":"Van Tassell","year":"2013","journal-title":"Circulation"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.67.3.753","article-title":"Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes","volume":"67","author":"Chung","year":"1990","journal-title":"Impairment Signal transduction Circ Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1999.276.1.H141","article-title":"Suppression of beta-adrenergic responsiveness of L-type Ca2+ current by IL-1beta in rat ventricular myocytes","volume":"276","author":"Liu","year":"1999","journal-title":"Am J Physiol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1997.272.6.H2591","article-title":"Involvement of ceramide in inhibitory effect of IL-1 beta on L-type Ca2+ current in adult rat ventricular myocytes","volume":"272","author":"Schreur","year":"1997","journal-title":"Am J Physiol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1995.268.2.C339","article-title":"G protein-mediated suppression of L-type Ca2+ current by interleukin-1 beta in cultured rat ventricular myocytes","volume":"268","author":"Liu","year":"1995","journal-title":"Am J Physiol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-002-0921-y","article-title":"Chronic exposure to interleukin 1beta induces a delayed and reversible alteration in excitation-contraction coupling of cultured cardiomyocytes","volume":"445","author":"Combes","year":"2002","journal-title":"Pflugers Arch"},{"key":"B75","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/01.res.81.4.493","article-title":"Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes","volume":"81","author":"McTiernan","year":"1997","journal-title":"Circ Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(00)00526-x","article-title":"Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes","volume":"35","author":"Tatsumi","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1476-5381.1995.tb14901.x","article-title":"The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha","volume":"114","author":"Schulz","year":"1995","journal-title":"Br J Pharmacol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.90.1.375","article-title":"Induction of nitric oxide synthase gene by interleukin-1 beta in cultured rat cardiocytes","volume":"90","author":"Tsujino","year":"1994","journal-title":"Circulation."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033438","article-title":"Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure","volume":"7","author":"Van Tassell","year":"2012","journal-title":"PloS One"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00795.2013","article-title":"Interleukin-18 mediates interleukin-1-induced cardiac dysfunction","volume":"306","author":"Toldo","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FJC.0000000000000106","article-title":"Interleukin-1\u03b2 blockade improves left ventricular systolic\/ diastolic function and restores contractility reserve in severe ischemic cardiomyopathy in the mouse","volume":"64","author":"Toldo","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.3.949","article-title":"Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum","volume":"183","author":"Kumar","year":"1996","journal-title":"J Exp Med"},{"key":"B83","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.151.3.1682","article-title":"Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis","volume":"151","author":"Lane","year":"1993","journal-title":"J Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.94.11.2930","article-title":"Persistent expression of cytokine in the chronic stage of viral myocarditis in mice","volume":"94","author":"Shioi","year":"1996","journal-title":"Circulation."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291x(91)91219-3","article-title":"Detection of interleukin and interleukin-receptor mRNA in human heart by polymerase chain reaction","volume":"181","author":"Han","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.035733","article-title":"Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy","volume":"91","author":"Vanderheyden","year":"2005","journal-title":"Heart"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021788","article-title":"Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis","volume":"197","author":"Eriksson","year":"2003","journal-title":"J Exp Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1161\/circ.105.11.1278","article-title":"Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis","volume":"105","author":"Lim","year":"2002","journal-title":"Circulation."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000160348.75918.CA","article-title":"Effect of hydrodynamics-based gene delivery of plasmid DNA encoding interleukin-1 receptor antagonist-Ig for treatment of rat autoimmune myocarditis: possible mechanism for lymphocytes and noncardiac cells","volume":"111","author":"Liu","year":"2005","journal-title":"Circulation"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(97)00494-4","article-title":"Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure","volume":"31","author":"Tsutamoto","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00395-014-0449-2","article-title":"Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis","volume":"109","author":"Savvatis","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"B92","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0000000000001194","article-title":"Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use","volume-title":"J Clin Rheumatol","author":"Campochiaro","year":"2019"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01932","article-title":"MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis","volume":"8","author":"Alivernini","year":"2018","journal-title":"Front Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01611","article-title":"IL-1-IL-17 Signaling Axis Contributes to Fibrosis and Inflammation in Two Different Murine Models of Systemic Sclerosis","volume":"9","author":"Park","year":"2018","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.213157","article-title":"Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy","volume":"106","author":"Baldeviano","year":"2010","journal-title":"Circ Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxs056","article-title":"IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKC\u03b2\/Erk1\/2\/NF-\u03baB-dependent signaling pathway","volume":"24","author":"Liu","year":"2012","journal-title":"Int Immunol"},{"key":"B97","article-title":"Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I\/II biomarker trial","author":"Mantero","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32285","article-title":"IL-1R1\/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice","volume":"117","author":"Gasse","year":"2007","journal-title":"J Clin Invest"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201412-2150LE","article-title":"Treating pulmonary silicosis by blocking interleukin 1","volume":"191","author":"Cavalli","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B100","article-title":"Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study","volume-title":"Lancet Rheumatol","author":"Cavalli","year":"2020"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1900154","DOI":"10.1183\/13993003.00154-2019","article-title":"IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis","volume":"54","author":"Birnhuber","year":"2019","journal-title":"Eur Respir J"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000378","article-title":"Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded, Placebo-Controlled Pilot Study","volume":"67","author":"Van Tassell","year":"2016","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005036","article-title":"IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction","volume":"11","author":"Van Tassell","year":"2018","journal-title":"Circ Heart Fail"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.7326\/L18-0315","article-title":"Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition","volume":"169","author":"De Luca","year":"2018","journal-title":"Ann Intern Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2014.992949","article-title":"Efficacy and safety of biological agents in adult-onset Still\u2019s disease","volume":"44","author":"Cavalli","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1080\/21678707.2017.1285226","article-title":"Advances in potential targeted therapies for Erdheim-Chester disease","volume":"5","author":"Cavalli","year":"2017","journal-title":"Expert Opin Orphan Drugs"},{"key":"B108","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejim.2020.04.050","article-title":"Therapeutic strategies for virus-negative myocarditis: a comprehensive review","volume":"77","author":"De Luca","year":"2020","journal-title":"Eur J Intern Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.05.086","article-title":"Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra)","volume":"160","author":"Vassilopoulos","year":"2012","journal-title":"Int J Cardiol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01233","article-title":"Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim\u2013Chester Disease","volume":"1","author":"Tomelleri","year":"2018","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13075-019-1843-9","article-title":"Efficacy of canakinumab as first-line biologic agent in adult-onset Still\u2019s disease","volume":"21","author":"Cavalli","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1177\/2047487319879534","article-title":"Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study","volume":"15","author":"Imazio","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial","volume":"316","author":"Brucato","year":"2016","journal-title":"JAMA."},{"key":"B114","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis","volume":"384","author":"Klein","year":"2021","journal-title":"N Engl J Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/FJC.0000000000000701","article-title":"Inhibiting NLRP3 inflammasome activity in acute myocardial infarction: a review of pharmacologic agents and clinical outcomes","volume":"74","author":"Buckley","year":"2019","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.653950\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T18:53:39Z","timestamp":1698087219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.653950\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":115,"alternative-id":["10.3389\/fimmu.2021.653950"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.653950","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"article-number":"653950"}}